Prosecution Insights
Last updated: October 25, 2026
Application No. 17/980,482

SYSTEM AND METHOD FOR PROVIDING AND AGGREGATING BIOSIGNALS AND ACTION DATA

Final Rejection §DOUBLEPATENT
Filed
Nov 03, 2022
Priority
May 25, 2012 — provisional 61/652,040 +3 more
Examiner
VANNI, GEORGE STEVEN
Art Unit
1686
Tech Center
1600 — Biotechnology & Organic Chemistry
Assignee
Emotiv Inc.
OA Round
2 (Final)
67%
Grant Probability
Favorable
3-4
OA Rounds
1m
Est. Remaining
92%
With Interview

Examiner Intelligence

Grants 67% — above average
67%
Career Allowance Rate
405 granted / 606 resolved
+6.8% vs TC avg
Strong +25% interview lift
Without
With
+25.2%
Interview Lift
resolved cases with interview
Typical timeline
4y 0m
Avg Prosecution
51 currently pending
Career history
651
Total Applications
across all art units

Statute-Specific Performance

§101
29.2%
-10.8% vs TC avg
§103
24.6%
-15.4% vs TC avg
§102
7.3%
-32.7% vs TC avg
§112
29.5%
-10.5% vs TC avg
Black line = Tech Center average estimate • Based on career data from 606 resolved cases

Office Action

§DOUBLEPATENT
DETAILED ACTION This application is being examined under AIA first-to-file provisions. Status of claims Canceled: none Pending: 1-20 Withdrawn: none Examined: 1-20 Independent: 1 and 11 Allowable: none Rejections applied Abbreviations 112/b Indefiniteness PHOSITA "a Person Having Ordinary Skill In The Art before the effective filing date of the claimed invention" 112/b "Means for" BRI Broadest Reasonable Interpretation 112/a Enablement, Written description CRM "Computer-Readable Media" and equivalent language 112 Other IDS Information Disclosure Statement 102, 103 JE Judicial Exception 101 JE(s) 112/a 35 USC 112(a) and similarly for 112/b, etc. 101 Other N:N page:line x Double Patenting MM/DD/YYYY date format Priority As detailed on the 11/15/2022 filing receipt, this application claims priority to no earlier than 5/25/2012. All claims have been interpreted as being accorded this priority date. Withdrawal / revision of objections and/or rejections In view of the amendment and remarks: The objection to the title is withdrawn, and the amendment has been entered. The objections to the claims are withdrawn. The 112/b rejections are withdrawn. Regarding 112/f, the newly recited "processor" is interpreted as well-known, e.g. a computer processor, and the recited "controller" is followed by further recitation interpreted as being of sufficient algorithmic structure to cause the recitation not to invoke. The 112/a rejection is withdrawn. The 103 rejection is withdrawn in view of Applicant's 10/2/2026 remarks at pp. 17-20. It would not have been obvious to combine art teaching a camera or "optical sensor" in the recited context and for the required follow-on steps. The previous 101 rejections are withdrawn. Referring to 101 analysis as organized in MPEP 2106, the 101 rejections are withdrawn at least in view of the analysis Step 2A, 2nd prong, 1st consideration relating to an improvement over the previous state of the technology field integrating possible judicial exceptions into a practical application (MPEP 2106.04(d) and (d)(1)), the improvement in this instance comprising enabling EEG stimulus and acquisition and environmental monitoring based on and comparable across a set of users. Also, the 101 rejections are withdrawn at least in view of the analysis Step 2A, 2nd prong, 4th consideration relating to a transformation integrating possible judicial exceptions into a practical application (MPEP 2106.04(d) and 2106.05(c)), the transformation in this instance comprising at least the recited modification of a stimulus as informed by the identified JEs. Also, the 101 rejections are withdrawn at least in view of the analysis Step 2B relating to a non-conventional combination of additional elements causing the claim to read on significantly more than any recited JE (MPEP 2106.05(d)), the combination in this instance comprising at least the recited EEG, optical sensor, their outputs and application to a modified stimulus. In this regard, Applicant's 10/2/2026 remarks at pp. 8-15 also support withdrawal of the rejection. Rejections and/or objections not maintained from previous office actions are withdrawn. The following rejections and/or objections are either maintained or newly applied. They constitute the complete set applied to the instant application. Nonstatutory double patenting The nonstatutory double patenting rejection is based on a judicially created doctrine to prevent the improper timewise extension of the "right to exclude" granted by a patent and to prevent multiple suits against an accused infringer by different assignees of the same invention (MPEP 804.II.B, 1st para.). A nonstatutory double patenting rejection is appropriate where the conflicting claims (instant v. reference) are not identical, but an examined-application claim (instant claim) is not patentably distinct from a reference claim because the instant claim is either anticipated by, or would have been obvious over, the reference claim (MPEP 804.II.B, 2nd para.). In cases of double patenting rejections versus reference claims of pending applications, as opposed to claims of an issued patent, the rejections are provisional because the reference claims have not been patented. Presently, no rejections are provisional. A timely filed terminal disclaimer in compliance with 37 CFR 1.321(c) or 1.321(d) may be used to overcome an actual or provisional rejection based on nonstatutory double patenting provided the application or patent of the reference claim either is shown to be commonly owned with the instant application or claims an invention made as a result of activities undertaken within the scope of a joint research agreement. A registered attorney or agent of record may sign a terminal disclaimer. A terminal disclaimer signed by the assignee must comply fully with 37 CFR 3.73(b). Applicant may wish to consider electronically filing a terminal disclaimer (MPEP 1490.V pertains, along with https://www.uspto.gov/patents-application-process/applying-online/eterminal-disclaimer). Electronic filing may lead to faster approval of the disclaimer. Also, if filing electronically, Applicant is encouraged to notify the examiner by telephone so that examination may resume more quickly. The USPTO Internet website contains terminal disclaimer forms which may be used. Please visit www.uspto.gov/patent/patents-forms. The actual filing date of the application in which the form is filed determines what form (e.g., PTO/SB/25, PTO/SB/26, PTO/AIA /25, or PTO/AIA /26) should be used. A web-based eTerminal Disclaimer may be filled out completely online using web-screens. An eTerminal Disclaimer that meets all requirements is auto-processed and approved immediately upon submission. For more information about eTerminal Disclaimers, refer to www.uspto.gov/patents/apply/applying-online/eterminal-disclaimer. Double patenting rejections of instant claims 1-20 Instant claims 1-20 are rejected on the grounds of nonstatutory double patenting as unpatentable over one or more claims in reference patent 9,867,548 (from application 13/903,806) in view of Pohlmeyer (NPL as cited on the attached "Notice of References Cited" form 892). Although the reference claims are not identical to the instant claims, in a BRI they also are not patentably distinct from the instant claims: either (i) because the instant claims recite obviously equivalent or broader limitations in comparison to the reference claims or (ii) because the instant claims recite limitations which are obvious over the cited art. It is not clear that the instant claims recite limitations which are narrower than limitations in the reference claims. Also, the reasons above for withdrawing the art rejections do not clearly support withdrawal of the double patenting rejection, e.g. one or more reference claims recite those limitations which distinguished the art. It would have been obvious in view of the cited art to modify reference claims to arrive at the rejected instant claims. Either the instant limitations are interpreted as reading on a reference limitation, or the instant limitations would have been obvious in view of the cited art. That is, to the extent that any instant claims are narrower than reference claims, then any such narrowing would have been obvious over the cited art. Conclusion No claim is allowed. Applicant's amendments necessitated the new grounds for rejection in this action. Accordingly, THIS ACTION IS MADE FINAL. See MPEP § 706.07(a). Applicant is reminded of the extension of time policy as set forth in 37 CFR 1.136(a). A shortened statutory period for reply to this final action is set to expire THREE MONTHS from the mailing date of this action. In the event a first reply is filed within TWO MONTHS of the mailing date of this final action and the advisory action is not mailed until after the end of the THREE-MONTH shortened statutory period, then the shortened statutory period will expire on the date the advisory action is mailed, and any extension fee pursuant to 37 CFR 1.136(a) will be calculated from the mailing date of the advisory action. In no event, however, will the statutory period for reply expire later than SIX MONTHS from the date of this final action. Inquiries Information regarding the filing, management and status of patent applications which are published (available to all users) or unpublished (available to registered users) may be obtained from the Patent Center: https://patentcenter.uspto.gov. Further is available at https://www.uspto.gov/patents/apply/patent-center, and information about filing in DOCX format is available at https://www.uspto.gov/patents/docx. The Electronic Business Center (EBC) at 866-217-9197 (toll-free) is available for additional questions, and assistance from a Customer Service Representative is available at 800-786-9199 (IN USA OR CANADA) or 571-272-1000. The examiner for this Office action, G. Steven Vanni, may be contacted at: (571) 272-3855 Tu-F 8-7 (ET). If attempts to reach the examiner by telephone are unsuccessful, the examiner’s supervisor, Larry D. Riggs, II, may be reached at (571) 270-3062. /G. STEVEN VANNI/Primary patents examiner, Art Unit 1686
Read full office action

Prosecution Timeline

Nov 03, 2022
Application Filed
Apr 03, 2026
Non-Final Rejection mailed — §DOUBLEPATENT
Sep 15, 2026
Interview Requested
Oct 02, 2026
Response Filed
Oct 06, 2026
Applicant Interview (Telephonic)
Oct 15, 2026
Final Rejection mailed — §DOUBLEPATENT (current)

Precedent Cases

Applications granted by this same examiner with similar technology

Patent 12770713
GENERATIVE PROTEIN DESIGN WITH COMPOSABLE ENERGY-BASED MODELS
1y 3m to grant Granted Oct 20, 2026
Patent 12758619
SYSTEM PROVIDING DOSE RECOMMENDATIONS FOR BASAL INSULIN TITRATION
5y 10m to grant Granted Oct 13, 2026
Patent 12762151
VARIANT PATHOGENICITY SCORING AND CLASSIFICATION AND USES THEREOF
5y 2m to grant Granted Oct 13, 2026
Patent 12752004
IMMUNE MOTIFS IN PRODUCTS FROM DOMESTIC ANIMALS
5y 12m to grant Granted Oct 06, 2026
Patent 12753429
METHODS AND SYSTEMS FOR AUTOMATED COUNTING AND CLASSIFYING COLONIES OF MICROORGANISMS
5y 8m to grant Granted Oct 06, 2026
Study what changed to get past this examiner. Based on 5 most recent grants.

Strategy Recommendation AI-generated — please review before filing

Get a prosecution strategy drawn from examiner precedents, rejection analysis, and claim mapping.
Typically takes 5-10 seconds — AI-generated, attorney review required before filing

Prosecution Projections

3-4
Expected OA Rounds
67%
Grant Probability
92%
With Interview (+25.2%)
4y 0m (~1m remaining)
Median Time to Grant
Moderate
PTA Risk
Based on 606 resolved cases by this examiner. Grant probability derived from career allowance rate.

Sign in with your work email

Enter your email to receive a magic link. No password needed.

Personal email addresses (Gmail, Yahoo, etc.) are not accepted.

Free tier: 3 strategy analyses per month